HBA Technology
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Our focus on cardiovascular disease research and treatments
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Gastrointestinal (GI) cancers
Gastrointestinal cancers include cancers of the esophagus, stomach, liver, pancreas, colon, and rectum.
Bladder cancer
The most common form of bladder cancer is urothelial cancer, accounting for about 90% of cases. Urothelial cancer begins in the urothelial cells, which line the urethra, bladder, ureters, renal pelvis and some other organs.
Our research in action
Our relentless focus on achieving the next breakthrough in cancer care is inspired by the lives we aim to prolong and protect. We’re following the science to discover innovations that can help patients no matter what stage of cancer they have, or so they may never be diagnosed with some types at all.
Our three areas of focus in oncology research:
Discovery & development
We're focused on transforming novel science into groundbreaking medicines and vaccines for patients.
Drug discovery
Drug discovery and development is a complex and lengthy endeavor. It requires creativity, tenacity and agility and the expertise of thousands of scientists working diligently toward our goal to save and improve lives around the world.
Meet our scientists
Innovation is fueled by diverse expertise and backgrounds. Our R&D leaders are pushing scientific boundaries at Merck. Meet our scientists.
Dean Li
Senior vice president and head, discovery, preclinicaldevelopment and translational medicine
Dean Li
Senior vice president and head, discovery, preclinicaldevelopment and translational medicine
Dean Li
Senior vice president and head, discovery, preclinical development and translational medicine
